Print the page
Increase font size
Palantir’s Biggest Backer Isn’t on Wall Street

Posted June 02, 2025

Today's Tech FWD

By Today's Tech FWD

Palantir’s Biggest Backer Isn’t on Wall Street

Chris Campbell:

Why Palantir Has Been the Single Best Trump Trade

Palantir is quickly cozying up to Uncle Sam. New reporting from The New York Times reveals Palantir has pulled in over $113 million in government contracts since Trump returned to the White House, and that doesn’t even include a fresh $800 million Defense Department deal. Traders who bet on Trump-linked companies tied to national security are being vindicated, and Palantir is leading the pack.

Sure, Palantir is riding the AI boom. But its real advantage is deeper — a long-standing, now supercharged relationship with Washington. With Peter Thiel’s political ties (including his early backing of Vice President JD Vance), Palantir is at the intersection of AI innovation and Trump’s renewed focus on defense and intelligence spending. Uncle Sam remains its largest client, and this administration shows no sign of cutting back.

Now Palantir is flirting with new record highs, proving that traders who saw the political and technological alignment were right. In a market chasing the next AI winner, Palantir isn’t just another AI stock — it’s the AI Trump trade.

⇒ Read More Here

Click here to learn more

Enrique Abeyta:

Never Fight the Trend

“Past performance is not indicative of future results.”

Stop me if you’ve heard this one before.

It’s the boilerplate disclaimer stamped on just about every investment product on Wall Street. You’ll find it in prospectuses, pitch decks, and fund marketing materials.

It’s treated as gospel. But in my experience, it’s dead wrong.

In fact, past performance is one of the best indicators of future results — if you know how to interpret it correctly.

⇒ Read More Here

Click here to learn more

James Altucher:

Trump’s 2025 Tariff Revolution

James sits down with Wilbur Ross, former Secretary of Commerce and seasoned investor, for a candid and highly detailed discussion on tariffs, China, inflation, pharmaceutical policy, and the state of the U.S. economy. 

Ross offers a firsthand look at the economic strategies being proposed for a possible second Trump administration — explaining why blanket tariffs might make sense, what’s really going on with China and rare earths, and how executive power is being used to bypass bureaucratic gridlock.

Listeners will get a rare window into how economic policy is being formed, the political forces shaping it, and what it all means for growth, inflation, and American manufacturing.

⇒ Read More Here

The Nvidia Killer's Wild IPO

The Nvidia Killer's Wild IPO

Posted May 15, 2026

By Today's Tech FWD

“Nvidia killer.” That’s the phrase suddenly getting attached to Cerebras Systems after one of the wildest IPO debuts we’ve seen in years.
Dems Get Foggy on CLARITY

Dems Get Foggy on CLARITY

Posted May 14, 2026

By Today's Tech FWD

The Senate Banking Committee has voted to advance the Clarity Act, a key piece of cryptocurrency legislation, to a full Senate vote.
America’s AI Elite Journey to China

America’s AI Elite Journey to China

Posted May 13, 2026

By Today's Tech FWD

Prominent U.S. executives from Big Tech and Wall Street to agriculture and aerospace are joining President Donald Trump on his diplomatic trip to China this week.
Musk’s Lost OpenAI Dynasty

Musk’s Lost OpenAI Dynasty

Posted May 12, 2026

By Today's Tech FWD

OpenAI CEO Sam Altman finally took the stand this morning to defend himself against his former cofounder Elon Musk’s lawsuit challenging OpenAI’s corporate structure.
The Dark Hum of the AI Economy

The Dark Hum of the AI Economy

Posted May 11, 2026

By Today's Tech FWD

Data center projects are facing new resistance from residents and communities over their noise pollution – including inaudible infrasound.
The SpaceX Backdoor Trap

The SpaceX Backdoor Trap

Posted May 08, 2026

By Today's Tech FWD

Several tokens supposedly offer a backdoor way into Elon Musk’s SpaceX before the big IPO – but are any of them actually worth buying?